User profiles for A. Narendran

Aru Narendran

Alberta Children's Hospital and The University of Calgary
Verified email at ucalgary.ca
Cited by 9617

[HTML][HTML] Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis

S Tran, TH Truong, A Narendran - European journal of cancer, 2021 - Elsevier
Background Efficacy and safety data of COVID-19 vaccines among cancer populations have
been limited; however, preliminary data from recent studies have emerged regarding their …

Tumour exosome integrins determine organotropic metastasis

…, VD Dumont-Cole, K Kramer, LH Wexler, A Narendran… - Nature, 2015 - nature.com
Ever since Stephen Paget’s 1889 hypothesis, metastatic organotropism has remained one
of cancer’s greatest mysteries. Here we demonstrate that exosomes from mouse and human …

Profound block in thymocyte development in mice lacking p56lck

…, DP Siderovskid, W Van Ewijk, A Narendran… - Nature, 1992 - nature.com
THE protein Lck (p56 lck ) has a relative molecular mass of 56,000 and belongs to the Src
family of tyrosine kinases 1–3 . It is expressed exclusively in lymphoid cells, predominantly in …

[HTML][HTML] Chemical and conformational diversity of modified nucleosides affects tRNA structure and function

VYP Väre, ER Eruysal, A Narendran, KL Sarachan… - Biomolecules, 2017 - mdpi.com
RNAs are central to all gene expression through the control of protein synthesis. Four major
nucleosides, adenosine, guanosine, cytidine and uridine, compose RNAs and provide …

Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4

…, TM Kündig, SR Sambhara, A Narendran… - Nature, 1991 - nature.com
T CELLS express T-cell antigen receptors (TCR) for the recognition of antigen in conjunction
with the products of the major histocompatibility complex 1,2 . They also express two key …

[HTML][HTML] Survivin as a preferential target for cancer therapy

M Mobahat, A Narendran, K Riabowol - International journal of molecular …, 2014 - mdpi.com
Cancer is typically a consequence of imbalance between cell death and proliferation in a way
favorable to cell proliferation and survival. Most conventional cancer therapies are based …

Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development

…, A Wakeham, J Potter, CL Furlonger, A Narendran… - Cell, 1993 - cell.com
Interferon regulatory factor 1 (IRF-1), a transcriptional activator, and its antagonistic repressor,
IRF-2, were originally identified as regulators of the type I interferon (IFN) system. We have …

Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional …

PM Miettunen, A Narendran, A Jayanthan… - …, 2011 - academic.oup.com
SIR, Macrophage activation syndrome (MAS) belongs to the haemophagocytic lymphohistiocytic
(HLH) disorders, and is one of the most feared complications of paediatric inflammatory …

Human T cell generation is restored in CD3δ severe combined immunodeficiency through adenine base editing

…, KA Everette, A Azzun, H Gelfer, CS Seet, A Narendran… - Cell, 2023 - cell.com
CD3δ SCID is a devastating inborn error of immunity caused by mutations in CD3D, encoding
the invariant CD3δ chain of the CD3/TCR complex necessary for normal thymopoiesis. …

[HTML][HTML] GM-CSF increases mucosal and systemic immunogenicity of an H1N1 influenza DNA vaccine administered into the epidermis of non-human primates

PT Loudon, EJ Yager, DT Lynch, A Narendran… - PloS one, 2010 - journals.plos.org
Background The recent H5N1 avian and H1N1 swine-origin influenza virus outbreaks
reaffirm that the threat of a world-wide influenza pandemic is both real and ever-present. …